All peptides
Tesamorelin + Ipamorelin
Also known as: Long-acting GHRH + GHS blend
Research / Investigational
Research blend pairing tesamorelin (an FDA-approved GHRH analog) with ipamorelin for GH-axis studies.
Buy Tesamorelin + Ipamorelin on American Peptides
Affiliate link — we may earn a commission at no extra cost to you.
Overview
Research blend pairing tesamorelin (an FDA-approved GHRH analog) with ipamorelin for GH-axis studies.
FDA Approval Status
Not approved by the FDA. Investigational or intended for research purposes only.
Mechanism of Action
GHRH-receptor activation with ghrelin-receptor agonism.
Current Research
Individual peptides studied; blend used off-label in research.
Research strength: Preliminary
Potential Medical Uses
- Tesamorelin alone approved for HIV-associated lipodystrophy
Potential Benefits
- Sustained GH pulses (research)
Known Side Effects
- Injection-site reactions
- Fluid retention
- Joint aches
Contraindications
- Active malignancy
- Pregnancy
Drug Interactions
- Insulin
Administration Methods
- Subcutaneous injection (research)
Half-life
Tesamorelin ~26 min; ipamorelin ~2 h
Reconstitution
Bacteriostatic water.
Storage & Handling
Refrigerated; use within ~30 days.
References & Sources
Frequently Asked Questions
Information on this page is educational and general in nature. It is not medical advice. Consult a qualified healthcare professional before making any medical decisions.